Jubilant Life Sciences is seeking shareholders’ approval through postal ballot/e-voting to raise up to Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. Approval to the board to raise the amount also stipulates that this could be done in one or more series/tranches during a period of one year from the date of passing the resolution.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
